On this page
Bronchiectasis has two possible schedular paths in 38 CFR § 4.97 (opens in a new tab), Diagnostic Code 6601. VA can rate the disease through the DC 6601 infection-and-sputum criteria, or rate pulmonary impairment as chronic bronchitis under DC 6600.
The code also defines an incapacitating episode precisely: it requires bed rest and treatment by a physician. Antibiotics appear in several percentage criteria, but antibiotic use is not part of that episode definition.
TL;DR
- DC 6601 provides 10, 30, 60, and 100 percent levels.
- The infection path considers total annual duration of incapacitating infection episodes, cough, sputum, hemoptysis, weight loss, and antibiotic treatment.
- An incapacitating episode requires bed rest and treatment by a physician.
- Antibiotic frequency and duration are separate facts that set the 10, 30 and 60 percent levels.
- VA may instead rate pulmonary impairment as chronic bronchitis under DC 6600.
- Section 4.96(a) bars stacking bronchiectasis with another listed respiratory rating and calls for one rating for the predominant disability.
- Bronchiectasis is a chronic disease listed in § 3.309(a), with a possible one-year presumption when the service and timing requirements in § 3.307 are met.
- Bronchiectasis is not listed as a PACT Act toxic-exposure presumptive disease.
Bronchiectasis VA rating criteria (DC 6601)
Here is DC 6601 as it reads in the current regulation.
100 percent: With incapacitating episodes of infection of at least six weeks total duration per year
60 percent: With incapacitating episodes of infection of four to six weeks total duration per year, or; near constant findings of cough with purulent sputum associated with anorexia, weight loss, and frank hemoptysis and requiring antibiotic usage almost continuously
30 percent: With incapacitating episodes of infection of two to four weeks total duration per year, or; daily productive cough with sputum that is at times purulent or blood-tinged and that requires prolonged (lasting four to six weeks) antibiotic usage more than twice a year
10 percent: Intermittent productive cough with acute infection requiring a course of antibiotics at least twice a year
Or rate according to pulmonary impairment as for chronic bronchitis (DC 6600).
Note: An incapacitating episode is one that requires bedrest and treatment by a physician.
At 10 percent, the measure is antibiotic courses for acute infections. At 30 and 60 percent there are two ways in: the total weeks of incapacitating episodes in a year, or a pattern of cough, sputum and antibiotic use. Only incapacitating episodes reach 100 percent. The annual duration is cumulative, so keep the start and end dates of each qualifying episode rather than reporting only the number of infections.
What counts as an incapacitating episode
Both parts of the note matter. Self-directed rest at home without physician treatment does not meet the definition, and a routine appointment without required bed rest does not establish it either. A course of antibiotics is not an episode by itself; antibiotic courses count toward the cough and sputum criteria instead. A good log records the infection dates, physician, bed-rest instruction, antibiotic name and duration, sputum findings, hemoptysis, weight change, and total incapacitating days.
Rating bronchiectasis as chronic bronchitis (DC 6600)
The chronic bronchitis path uses FEV-1, FEV-1/FVC, DLCO (SB), maximum exercise capacity, and severe findings such as cor pulmonale, pulmonary hypertension, acute respiratory failure or outpatient oxygen therapy. When VA uses it, the pulmonary function test rules in 38 CFR § 4.96(d) (opens in a new tab) apply. They cover post-bronchodilator values, a missing DLCO, test results that conflict with each other or with the clinical findings, and the severe findings that can be rated without a test.
The decision should say which path describes the disability and why. Submit both the infection record and a complete PFT report when either could be more favorable.
Bronchiectasis with COPD, asthma or chronic bronchitis: one rating
Section 4.96(a) bars combining ratings under DCs 6600 through 6817 and 6822 through 6847. VA assigns a single rating under the code that reflects the predominant disability, with elevation to the next higher level when the severity of the overall disability warrants it.
That rule matters when the record also lists chronic bronchitis, COPD, asthma, or constrictive bronchiolitis. Coexisting diagnoses and symptoms remain evidence, but overlapping respiratory impairment is not paid as multiple schedular ratings.
Is bronchiectasis service connected?
The one-year chronic disease presumption
Bronchiectasis appears in the chronic-disease list in 38 CFR § 3.309(a) (opens in a new tab). Under § 3.307(a) (opens in a new tab), the ordinary chronic-disease presumption generally requires at least 90 days of qualifying continuous service and manifestation to a degree of 10 percent or more within one year after separation.
The diagnosis itself does not have to fall inside that year. Under § 3.307(c), the record has to show characteristic signs of the disease to that degree within the year, followed without unreasonable delay by a definite diagnosis. Repeated cough or infections within the year are not automatically bronchiectasis without competent medical evidence tying them to the later diagnosis.
Bronchiectasis and the PACT Act
This one-year route is separate from the PACT Act. The PACT Act list in 38 U.S.C. § 1120(b) names chronic bronchitis, COPD, constrictive or obliterative bronchiolitis, emphysema, granulomatous disease, interstitial lung disease, pleuritis, pulmonary fibrosis and sarcoidosis among its lung conditions, but not bronchiectasis. VA's current burn pit rule, 38 CFR § 3.320 (opens in a new tab), covers asthma, rhinitis, sinusitis and certain rare cancers. VA's October 1, 2024 proposal to write the full § 1120 list into § 3.320 (89 FR 79815), still not final, does not add bronchiectasis either. An exposure claim is still possible, but it needs direct evidence and a medical opinion.
Direct and secondary service connection
Direct service connection under 38 CFR § 3.303 (opens in a new tab) may be supported by documented in-service pneumonia or severe respiratory infections followed by competent medical evidence linking that history to permanent airway damage. Past infection is a common cause: it was the most common identified cause in a registry of more than 10,000 adults with bronchiectasis in China (PMID 39805296). A claimed airborne-hazard route also needs a case-specific medical nexus when no statutory presumption applies.
Secondary service connection under 38 CFR § 3.310 (opens in a new tab) requires medical evidence that a service-connected disease or its treatment caused the bronchiectasis or made it worse, meaning it would be less severe but for that condition. A shared respiratory diagnosis or overlapping symptoms do not establish that relationship by themselves.
Why VA denies bronchiectasis claims
Across 186 decided Board rulings on bronchiectasis from 2021 to 2026, 26.9% were granted, 25.3% denied and 47.8% remanded. A ruling is one issue the Board decided in one decision; one decision often rules on several issues. That grant rate is 2.2 percentage points above the 24.7 percent across all decided Board rulings. Too few bronchiectasis rulings reached the Board for a reliable breakdown of denial or remand reasons; the Board section below shows how bronchiectasis appeals have gone since 1992.
The gaps below are evidence checks, not a ranking of Board denials.
- No high-resolution CT or specialist diagnosis, so the record shows cough and infections but not bronchiectasis. A high-resolution chest CT confirms the diagnosis (PMID 26307756).
- Treating every antibiotic course as an incapacitating episode.
- Reporting the number of infections without total annual duration.
- Omitting the physician bed-rest instruction.
- Ignoring the alternative DC 6600 path, or submitting breathing tests without post-bronchodilator values.
- Adding overlapping respiratory percentages despite § 4.96.
- Saying no presumption covers bronchiectasis and missing §§ 3.307 and 3.309.
- Calling bronchiectasis a PACT Act presumptive condition.
A file that avoids these gaps holds the CT and diagnosis, dated infection and treatment records with any physician-ordered bed rest, antibiotic names and course lengths, sputum, hemoptysis and weight records, complete pre- and post-bronchodilator PFTs, records from the first year after separation when the presumption may apply, and a medical opinion for any direct or secondary theory.
Questions veterans ask about bronchiectasis
What is the VA rating for bronchiectasis?
Bronchiectasis rates 10, 30, 60 or 100 percent under DC 6601, or on lung function under the chronic bronchitis criteria of DC 6600. At the 2026 rates for a veteran alone, that runs from $180.42 to $3,938.58 a month.
Is bronchiectasis a presumptive condition for veterans?
Only under the one-year chronic disease rule. It is on the 38 CFR § 3.309(a) list, so after 90 days or more of qualifying service it is presumed service connected if it reached 10 percent within one year of separation. It is not on the PACT Act list.
Does a course of antibiotics count as an incapacitating episode?
No. An incapacitating episode needs bed rest and treatment by a physician. Antibiotic courses count separately, toward the 10, 30 and 60 percent cough and sputum criteria.
Can I get separate VA ratings for bronchiectasis and COPD?
No. Under 38 CFR § 4.96(a), ratings for bronchiectasis, COPD, asthma and chronic bronchitis are not combined with each other. VA assigns one rating under the code for the predominant disability and can raise it one level when the overall disability warrants it.
Is VA changing the bronchiectasis rating criteria?
Not yet. VA's February 15, 2022 respiratory proposal (87 FR 8474) would rate bronchiectasis under a general respiratory formula based on lung function tests, oxygen consumption and METs instead of infection episodes. As of October 2026 it is still a proposal, so the current DC 6601 criteria apply.
Bottom Line
DC 6601 separates incapacitating infection episodes from antibiotic-based cough and sputum criteria, and it permits an alternative chronic-bronchitis rating for pulmonary impairment. Bronchiectasis also has a possible one-year chronic-disease presumption, distinct from the PACT Act. A complete record tracks physician-required bed rest, treatment, antibiotic duration, sputum findings, PFTs, and the exact service-connection route.
Related conditions and tools
Compare chronic bronchitis, COPD, asthma, and constrictive bronchiolitis. Review DC 6601 and DC 6600, and organize infection and functional evidence with the Statement Builder.
Methodology and Limitations
- Sources: DCs 6600 and 6601 in 38 CFR § 4.97, § 4.96, and §§ 3.303, 3.307, 3.309, 3.310 and 3.320, checked against the eCFR text in October 2026; 38 U.S.C. § 1120(b); the pending proposals at 87 FR 8474 (February 15, 2022) and 89 FR 79815 (October 1, 2024). Medical statements are from PubMed abstracts (PMIDs 26307756, 39805296).
- Board figures: Claim Raven's read of every Board decision from 2021 to 2026 that it holds, 510,968 decisions containing 1,376,193 rulings. That includes 186 decided Board rulings on bronchiectasis (203 rulings in all, counting dismissed and withdrawn issues). The Board section on this page breaks these down by era; those figures are computed from the data, not typed here.
- Limitations: Compensation amounts reflect the 2026 VA rate tables (effective December 1, 2025) for a single veteran with no dependents and change annually. BVA-level patterns reflect cases that appealed; most bronchiectasis claims resolve at the regional office level. Claim Raven is data analysis, not legal, medical, or VA-accredited advice.
